Skip to main content

Comprehensive gene and microRNA expression profiling reveals the crucial role of hsa-let-7i and its target genes in colorectal cancer metastasis

Abstract

Accumulating evidence has demonstrated that miRNAs play important roles in the occurrence and development of colorectal cancer (CRC). However, whether miRNAs are associated with the metastasis of CRC remains largely unexplored. The aim of the current study is to profile miRNAs in different CRC metastatic cell lines to identify the biomarkers in CRC metastasis. Gene and miRNA expression profiling was performed to analyze the global expression of mRNAs and miRNAs in the four human CRC cell lines (LoVo, SW480, HT29 and Caco-2) with different potential of metastasis. Expression patterns of mRNAs and miRNAs were altered in different CRC cell lines. By developing an integrated bioinformatics analysis of gene and miRNA expression patterns, hsa-let-7i was identified to show the highest degree in the microRNA-GO-network and microRNA-Gene-network. The expression level of hsa-let-7i was further validated by qRT-PCR in CRC cells. In addition, the targets of hsa-let-7i were predicted by two programs TargetScan and PicTar, and target genes were validated by expression profiling in the most epresentative LoVo and Caco-2 cell lines. Eight genes including TRIM41, SOX13, SLC25A4, SEMA4F, RPUSD2, PLEKHG6, CCND2, and BTBD3 were identified as hsa-let-7i targets. Our data showed the power of comprehensive gene and miRNA expression profiling and the application of bioinformatics tools in the identification of novel biomarkers in CRC metastasis.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Varol N, Konac E, Gurocak OS, Sozen S (2011) The realm of microRNAs in cancers. Mol Biol Rep 38:1079–1089

    PubMed  CAS  Google Scholar 

  2. Aslam MI, Taylor K, Pringle JH, Jameson JS (2009) MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 96:702–710

    PubMed  CAS  Google Scholar 

  3. Manikandan J, Aarthi JJ, Kumar SD, Pushparaj PN (2008) Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation 2:330–334

    PubMed  Google Scholar 

  4. Shan Z, Lin Q, Deng C, Li X, Huang W, Tan H, Fu Y, Yang M, Yu XY (2009) An efficient method to enhance gene silencing by using precursor microRNA designed small hairpin RNAs. Mol Biol Rep 36:1483–1489

    PubMed  CAS  Google Scholar 

  5. Yang L, Belaguli N, Berger DH (2009) MicroRNA and colorectal cancer. World J Surg 33:638–646

    PubMed  Google Scholar 

  6. Bandrés E, Cubedo E, Agirre X, Malumbres R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M, García-Foncillas J (2006) Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5:29

    PubMed  Google Scholar 

  7. Michael MZ, O’Connor SM, Van Holst Pellekaan NG, Young GP, James RJ (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1:882–891

    PubMed  CAS  Google Scholar 

  8. Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW (2005) Colorectal cancer. Lancet 365:153–165

    PubMed  Google Scholar 

  9. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad Ø (2004) Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 40:1593–1598

    PubMed  Google Scholar 

  10. Hamada K, Monnai M, Kawai K, Nishime C, Kito C, Miyazaki N, Ohnishi Y, Nakamura M, Suemizu H (2008) Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice. Int J Oncol 32:153–159

    PubMed  CAS  Google Scholar 

  11. Hou J, Wang P, Lin L, Liu X, Ma F, An H, Wang Z, Cao X (2009) MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 183:2150–2158

    PubMed  CAS  Google Scholar 

  12. Wright GW, Simon RM (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19:2448–2455

    PubMed  CAS  Google Scholar 

  13. Yang H, Crawford N, Lukes L, Finney R, Lancaster M, Hunter KW (2005) Metastasis predictive signature profiles pre-exist in normal tissues. Clin Exp Metastasis 22:593–603

    PubMed  CAS  Google Scholar 

  14. Clarke R, Ressom HW, Wang A, Xuan J, Liu MC, Gehan EA, Wang Y (2008) The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat Rev Cancer 8:37–49

    PubMed  CAS  Google Scholar 

  15. Tu K, Yu H, Hua YJ, Li YY, Liu L, Xie L, Li YX (2009) Combinatorial network of primary and secondary microRNA-driven regulatory mechanisms. Nucleic Acids Res 37:5969–5980

    PubMed  CAS  Google Scholar 

  16. Miller LD, Long PM, Wong L, Mukherjee S, McShane LM, Liu ET (2003) Optimal gene expression analysis by microarrays. Cancer Cell 2:353–361

    Google Scholar 

  17. Ramoni MF, Sebastiani P, Kohane IS (2002) Cluster analysis of gene expression dynamics. Proc Natl Acad Sci USA 99:9121–9126

    PubMed  CAS  Google Scholar 

  18. Schlitt T, Palin K, Rung J, Dietmann S, Lappe M, Ukkonen E, Brazma A (2003) From gene networks to gene function. Genome Res 13:2568–2576

    PubMed  CAS  Google Scholar 

  19. Dupuy D, Bertin N, Hidalgo CA, Venkatesan K, Tu D, Lee D, Rosenberg J, Svrzikapa N, Blanc A, Carnec A, Carvunis AR, Pulak R, Shingles J, Reece-Hoyes J, Hunt-Newbury R, Viveiros R, Mohler WA, Tasan M, Roth FP, Le Peuch C, Hope IA, Johnsen R, Moerman DG, Barabási AL, Baillie D, Vidal M (2007) Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat Biotechnol 25:663–668

    PubMed  CAS  Google Scholar 

  20. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32:D277–D280

    PubMed  CAS  Google Scholar 

  21. Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM (2006) WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics 7:30

    PubMed  Google Scholar 

  22. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R (2007) A systems biology approach for pathway level analysis. Genome Res 17:1537–1545

    PubMed  CAS  Google Scholar 

  23. Draghici S, Tarca AL, Yu L, Ethier S, Romero R (2008) KUTE-BASE: storing, downloading and exporting MIAME-compliant microarray experiments in minutes rather than hours. Bioinformatics 24:738–740

    PubMed  CAS  Google Scholar 

  24. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW (2009) MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361:1437–1447

    PubMed  CAS  Google Scholar 

  25. Gustin MP, Paultre CZ, Randon J, Bricca G, Cerutti C (2008) Functional meta-analysis of double connectivity in gene coexpression networks in mammals. Physiol Genomics 34:34–41

    PubMed  CAS  Google Scholar 

  26. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787–798

    PubMed  CAS  Google Scholar 

  27. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N (2005) Combinatorial microRNA target predictions. Nat Genet 37:495–500

    PubMed  CAS  Google Scholar 

  28. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793–1801

    PubMed  CAS  Google Scholar 

  29. Eder M, Scherr M (2005) MicroRNA and lung cancer. N Engl J Med 352:2446–2448

    PubMed  CAS  Google Scholar 

  30. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA (2009) MicroRNAs—the micro steering wheel of tumour metastases. Nat Rev Cancer 9:293–302

    PubMed  CAS  Google Scholar 

  31. Nakajima G, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki K, Yamamoto M, Ju J (2006) Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Cancer Genomics Proteomics 3:317–324

    PubMed  CAS  Google Scholar 

  32. Tanaka M, Fukuda Y, Mashima K, Hanai R (2005) Intracellular localization and domain organization of human TRIM41 proteins. Mol Biol Rep 32:87–93

    PubMed  CAS  Google Scholar 

  33. Takano Y, Kato Y, Masuda M, Ohshima Y, Okayasu I (1999) Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. J Pathol 189:194–200

    PubMed  CAS  Google Scholar 

  34. Sarkar R, Hunter IA, Rajaganeshan R, Perry SL, Guillou P, Jayne DG (2010) Expression of cyclin D2 is an independent predictor of the development of hepatic metastasis in colorectal cancer. Colorectal Dis 12:316–323

    PubMed  CAS  Google Scholar 

  35. Mermelshtein A, Gerson A, Walfisch S, Delgado B, Shechter-Maor G, Delgado J, Fich A, Gheber L (2005) Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas. Br J Cancer 93:338–345

    PubMed  CAS  Google Scholar 

  36. Akao Y, Nakagawa Y, Naoe T (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29:903–906

    PubMed  CAS  Google Scholar 

  37. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189–198

    PubMed  CAS  Google Scholar 

  38. Fang WJ, Lin CZ, Zhang HH, Qian J, Zhong L, Xu N (2007) Detection of let-7a microRNA by real-time PCR in colorectal cancer: a single-centre experience from China. J Int Med Res 35:716–723

    PubMed  CAS  Google Scholar 

  39. Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M, Sültmann H, Lyko F (2007) The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 67:1419–1423

    PubMed  CAS  Google Scholar 

  40. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67:9762–9770

    PubMed  CAS  Google Scholar 

  41. Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L, Johnstone CN, Chen XM, Liu CG, Huang Q, Katsaros D, Calin GA, Weber BL, Bützow R, Croce CM, Coukos G, Zhang L (2008) MicroRNA microarray identifies let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 68:10307–10314

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the National 973 Basic Research Program of China (No. 2008CB517403), the Grants from Shanghai Science and Technology Development Fund (No. 09JC1411600), the National 863 High Technology Foundation (No. 2009AA02Z118), and Doctoral Fund of Shanghai Jiao Tong University (No. BXJ201039).

Conflict of interests

The authors declare that they have no conflict of interests.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Huanlong Qin.

Additional information

Peng Zhang, Yanlei Ma, and Feng Wang have equally contributed to this paper.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Fig. 1S

Pathway analysis based on miRNA target genes. Significant pathways targeted by upregulated miRNA were shown. The vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (JPEG 182 kb)

Fig. 2S

MiRNA-Gene-network analysis. Red box nodes represented miRNA, blue cycle nodes represented mRNA, and edges showed the inhibitory effect of miRNA on mRNA. Upregulated and downregulated miRNAs had separate and specific targets. The five key miRNAs in the network were hsa-miR-130a, hsa-let-7i, hsa-miR-106b, hsa-let-7g, and hsa-miR-15b. (JPEG 752 kb)

Fig. 3S

MiRNA-GO-network analysis. The circle represented gene, the square represented miRNA, and their relationship was represented by one edge. The degree represented the contribution of individual miRNA or gene to the genes or miRNAs around. The six key miRNAs in the network were hsa-miR-371-3p, hsa-let-7i, hsa-let-7g, hsa-miR-15b, hsa-miR-199a-3p, and hsa-miR-26b. (JPEG 475 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zhang, P., Ma, Y., Wang, F. et al. Comprehensive gene and microRNA expression profiling reveals the crucial role of hsa-let-7i and its target genes in colorectal cancer metastasis. Mol Biol Rep 39, 1471–1478 (2012). https://doi.org/10.1007/s11033-011-0884-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-011-0884-1

Keywords

  • Colorectal cancer
  • Bioinformatics
  • hsa-let-7i
  • Metastasis